1. Home
  2. BY vs ANIP Comparison

BY vs ANIP Comparison

Compare BY & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BY

Byline Bancorp Inc.

HOLD

Current Price

$32.51

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BY
ANIP
Founded
1914
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
BY
ANIP
Price
$32.51
$76.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$33.50
$107.33
AVG Volume (30 Days)
157.7K
309.9K
Earning Date
04-22-2026
03-26-2026
Dividend Yield
1.51%
N/A
EPS Growth
3.00
N/A
EPS
2.12
2.15
Revenue
N/A
$206,547,000.00
Revenue This Year
$17.06
$44.10
Revenue Next Year
$2.84
$13.18
P/E Ratio
$15.27
$35.49
Revenue Growth
N/A
2.47
52 Week Low
$22.63
$56.71
52 Week High
$33.89
$99.50

Technical Indicators

Market Signals
Indicator
BY
ANIP
Relative Strength Index (RSI) 54.16 43.96
Support Level $32.00 $75.20
Resistance Level $33.89 $84.47
Average True Range (ATR) 0.83 2.52
MACD -0.18 -0.15
Stochastic Oscillator 43.46 39.91

Price Performance

Historical Comparison
BY
ANIP

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: